ArticleJournal of X-ray science and technology2022
Applying a radiomics-based CAD scheme to classify between malignant and benign pancreatic tumors using CT images.
Article in Journal of X-ray science and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.
- Diagnostic performance of artificial intelligence based on contrast-enhanced computed tomography in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.Abdominal radiology (New York) · 2026Pooled it
- Diagnostic assistance method for RR-TB/MDR-TB patients under treatment based on CNN-LSTM.Scientific reports · 2025Article
- Advancements in Radiomics-Based AI for Pancreatic Ductal Adenocarcinoma.Bioengineering (Basel, Switzerland) · 2025Review
- Deep learning-based MVIT-MLKA model for accurate classification of pancreatic lesions: a multicenter retrospective cohort study.La Radiologia medica · 2025Article
- Deep Learning Applications in Pancreatic Cancer.Cancers · 2024Review
- A Comparison of Computer-Aided Diagnosis Schemes Optimized Using Radiomics and Deep Transfer Learning Methods.Bioengineering (Basel, Switzerland) · 2022Article
- A multimodal artificial intelligence system for the detection and diagnosis of solid pancreatic lesions under EUS.Endoscopic ultrasoundArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundPancreatic cancer is one of the most aggressive cancers with approximate 10% five-year survival rate. To reduce mortality rate, accurate detection and diagnose of suspicious pancreatic tumors at an early stage plays an important role.
objectiveTo develop and test a new radiomics-based computer-aided diagnosis (CAD) scheme of computed tomography (CT) images to detect and classify suspicious pancreatic tumors.
methodsA retrospective dataset consisting of 77 patients who had suspicious pancreatic tumors detected on CT images was assembled in which 33 tumors are malignant. A CAD scheme was developed using the following 5 steps namely, (1) apply an image pre-processing algorithm to filter and reduce image noise, (2) use a deep learning model to detect and segment pancreas region, (3) apply a modified region growing algorithm to segment tumor region, (4) compute and select optimal radiomics features, and (5) train and test a support vector machine (SVM) model to classify the detected pancreatic tumor using a leave-one-case-out cross-validation method.
resultsBy using the area under receiver operating characteristic (ROC) curve (AUC) as an evaluation index, SVM model yields AUC = 0.750 with 95% confidence interval [0.624, 0.885] to classify pancreatic tumors.
conclusionsStudy results indicate that radiomics features computed from CT images contain useful information associated with risk of tumor malignancy. This study also built a foundation to support further effort to develop and optimize CAD schemes with more advanced image processing and machine learning methods to more accurately and robustly detect and classify pancreatic tumors in future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.